Status:
COMPLETED
Evaluation of Intestinal Secretion of Antibodies and Auto-antibodies Associated With Crohn's Disease
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Crohn's Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
We propose to study the intestinal secretion of ASCA by evaluating them in biopsy culture supernatants from a cohort of patients suffering from CD (n=80) and a cohort of control patients (UC (n=40) an...
Detailed Description
Its diagnosis is based upon clinical, endoscopic and histological parameters but recent studies have shown that seric evaluation of immunological markers (anti-Saccharomyces cerevisiae antibodies (ASC...
Eligibility Criteria
Inclusion
- Patients reached by disease of crohn
- patients reached by hemorrhagic first side-colitis
Exclusion
- Forms ileales or ano-périneales pure of disease of crohn
- indefinite colitis
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT00769236
Start Date
June 1 2008
End Date
August 1 2010
Last Update
August 28 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratoire d'Immunologie - Hopital de la Conception
Marseille, France, 13005